Biogen at aaic 2026: tau drug advances despite mixed trial readout

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Why is Biogen stock rallying today? Hisse Senetleri 0 2
A FDA approves at-home starting dose for Eisai, Biogen Alzheimer’s drug Hisse Senetleri 0 1
A Biogen to acquire Apellis Pharmaceuticals for $5.6 billion Hisse Senetleri 0 48
A Biogen stock falls on Apellis deal despite William Blair Outperform rating Hisse Senetleri 0 17
A Guggenheim reiterates Buy on Biogen stock after Apellis deal Hisse Senetleri 0 28
A Stifel reiterates Biogen stock rating after Apellis acquisition Hisse Senetleri 0 32
A Biogen to present litifilimab data for cutaneous lupus at AAD Hisse Senetleri 0 26
A Biogen at Wedbush ASN 2025: New Horizons in Kidney Disease Treatment Hisse Senetleri 0 37

Benzer konular

Üst